65,437 trials
Adult Anaplastic Astrocytoma · Adult Giant Cell Glioblastoma · Adult Gliosarcoma
Primary: Number of Dose Limiting Toxicity to Determine Maximum Tolerated Dose (MTD) of BMS-247550 in Patients With Recurrent or Progressive Malignant Glioma — 0; 0; NA; 0 DLTs
Acute Myeloid Leukemia
Primary: Overall Survival — 7.5; 6.1 Months — p=0.0305
Childhood Acute Lymphoblastic Leukemia in Remission · Childhood Acute Myeloid Leukemia in Remission · Childhood Chronic Myelogenous Leukemia
Primary: Duration of Severe Oral Mucositis (WHO Grade 3 or 4) — 4.5; 4.5 Number of days
Pain · Depression
Primary: Brief Pain Inventory Interference — 5.0; 6.5; 4.6 units on a scale — p=<0.001
B-cell Lymphoma · Indolent B-cell Lymphoma
Primary: Determine Complete Response Rate (CRR) of Increased Dose Rituximab in Indolent B-cell Lymphomas — 21 Participants
Childhood Acute Lymphoblastic Leukemia in Remission · Childhood Acute Myeloid Leukemia in Remission · Childhood Chronic Myelogenous Leukemia
Primary: Estimated Two-year Event-free Survival (EFS) — 66; 83 Percentage of patients
Hypertriglyceridemia · Diabetic Neuropathy
Primary: Efficacy Measures Are Nerve Conduction Studies, Specifically Changes in Conduction Amplitude. — 7.28; 7.14; 4.08; 3.80 uV
Major Depressive Disorder
Primary: Hamilton Depression Rating Scale (HDRS) — 17.2; 16.6; 7.6; 7.5 units on a scale
Diabetic Retinopathy
Primary: Per Patient Referral Accuracy — 318 Participants
Apnea of Prematurity · Hypoxia · Bradycardia
Primary: Change in Total Number of Episodes of Apnea/Breathing Pauses During Intervention and Without Intervention — 284.13; 174.27 breathing pauses
Night Eating Syndrome
Primary: Change in Symptoms of NES — 46.1; 11.8; 17.4; NA percentage of calories after dinner
Chronic Obstructive Pulmonary Disease
Primary: FEV1 AUC0-12 on Day 29 — 0.231; 0.197; 0.205; 0.011 Liters
Breast Cancer
Primary: Number of Participants With Response — 0 Participants
Liver Cancer
Primary: Disease Response Rate — 12.5 percentage of participants with response
Acute ST Elevation Myocardial Infarction
Primary: Infarct Size in the Territory of the Infarct Related Artery — 15.8; 15.0 percentage of LV mass